The FDA just approved yet another new, late stage melanoma therapy, nivolumab.  That makes a record, mind blowing seven new FDA approved drugs since 2011.

Melanoma StagesIn addition to nivolumab, other FDA-approved treatments for melanoma include ipilimumab (Yervoy, approved in 2011), peginterferon alfa-2b (2011), vemurafenib (Zelboraf, Genentech; 2011), dabrafenib (Tafinlar, GlaxoSmithKline; 2013), trametinib (Mekinist, GlaxoSmithKline; 2013), and pembrolizumab (2014).

Here’s a link to a Medscape.com article about it:

http://www.medscape.com/viewarticle/837065?src=wnl_edit_newsal&uac=144882PN

I have been touting multiple myeloma research as the most successful assault on cancer ever.  But while there are a dozen or more new myeloma drugs in the pipeline, there have only been seven new FDA approved myeloma therapies in the past ten years.

Melanoma/myeloma.  By any measure, they’re the champs!  Still no cure…

Feel good and keep smiling!  Pat

Leave a Reply